UC Berkeley Wellness Letter.com


 
password


What is my password?

What is the Subscriber's Corner?

What's New...


Back Issues • 2005–2007 Index • About Us

FROM THE SEPTEMBER 2008 ISSUE

Table of Contents
Ask the Experts
Can This Drug Prevent Prostate Cancer?
You may be surprised to hear that five years ago a large, long-awaited federal study found that a drug widely used to treat the urinary symptoms caused by prostate enlargement also reduces the risk of prostate cancer by 25%. The drug is finasteride; its brand name is Proscar. There was one problem, however: the study concluded that the drug reduced the risk of insignificant cancers, but seemed to increase the risk of more aggressive types. That finding largely quashed the hopes about finasteride as a preventive for prostate cancer—for a while. Recently, however, several analyses of the research, using more thorough and complete data, have shown that the initial scary finding about finasteride was misleading—that ultimately men taking finasteride had lower rates of all types of prostate cancer, including the aggressive ones. So why aren’t men dancing in the street, and all their doctors prescribing them finasteride?  Full Story

FROM THE WELLNESS GUIDE TO DIETARY SUPPLEMENTS

In focus this month: Coenzyme Q-10
Confused about all the hype and conflicting info about supplements?  Go to the Guide to Dietary Supplements
FROM OUR RECIPE FILE

Stalks vs. florets
In this month’s Wellness Letter, a reader asks us to compare the nutrients in broccoli stalks and florets. Our featured recipe is
Chopped Broccoli Piccata, makes good use of the whole thing.  Go to Recipe

FROM FOUNDATIONS OF WELLNESS

Here are the basics for staying healthy
30 major articles about exercise, nutrition, prevention, and self-care. Go to Foundations

 

 


 

Home  |  Wellness Letter  |  Subscriber's Corner  |  Foundations of Wellness  |  Subscribe!
Guide to Supplements  |  Wellness Recipes  |  Wellness Books  |  Site Map

About Us  |  Our Privacy Policy  |  Contact Us

© 2008 MediZine LLC. All rights reserved.